Rhett Brown

Rhett Brown, CFA, is a seasoned finance professional with extensive experience in healthcare equity analysis. Currently serving as Managing Director and Healthcare Equity Analyst at Lazard Asset Management since September 2005, Rhett brings a wealth of knowledge from previous roles, including Equity Analyst at Deutsche Bank Securities and Equity Research Associate at Volpe Brown Whelan & Company. Rhett's early career includes positions at Amersham, Applied Biosystems, and Immunologic Pharmaceutical Corporation, where foundational skills in marketing and research were developed. Academically, Rhett holds an MBA in Finance from The Wharton School and a BS in Biological Sciences with a focus on Molecular Biology from Stanford University.